Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 7402153 Closed-loop method for controlling insulin infusion
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
March 31, 2004
0
Date of Patent
July 22, 2008
0
Patent Application Number
10816021
0
Patent Citations Received
US Patent 12128215 Drug delivery device with integrated optical-based glucose monitor
0
US Patent 12119119 Methods and systems for real-time sensor measurement simulation
0
US Patent 12123654 System and method for maintaining efficiency of a fractal heat sink
0
US Patent 12121701 Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system
0
US Patent 12121700 Open-loop insulin delivery basal parameters based on insulin delivery records
0
US Patent 12126289 Devices and methods for controlling electromechanical actuators
0
US Patent 11672036 Method and system for controlling communication between devices of a wireless body area network for a medical device system
0
US Patent 11660394 Fluid infusion system that automatically determines and delivers a correction bolus
0
US Patent D987830 Analyte sensor inserter
0
US Patent 11670425 Translation modeling methods and systems for simulating sensor measurements
0
•••
Patent Inventor Names
Garry M. Steil
0
Kerstin Rebrin
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
7402153
0
Patent Primary Examiner
Kevin C. Sirmons
0
Find more entities like US Patent 7402153 Closed-loop method for controlling insulin infusion
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE